Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF.
暂无分享,去创建一个
G. Fonarow | C. O'connor | M. Walsh | C. Yancy | M. Gheorghiade | A. Curtis | G. Fonarow | N. Albert | W. G. Stough | M. Mehra | D. Reynolds | J. Heywood | M. Mcbride | C. O'Connor | M. McBride | Anne B. Curtis
[1] Nancy M Albert,et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. , 2007, Journal of the American College of Cardiology.
[2] S. Saba,et al. Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States from 1996 to 2001. , 2004, Journal of the American College of Cardiology.
[3] S G Thompson,et al. Incidence and aetiology of heart failure; a population-based study. , 1999, European heart journal.
[4] Ralph D'Agostino,et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. , 2004, The New England journal of medicine.
[5] J. Ornato,et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .
[6] J. Tu,et al. Quality of care and outcomes of older patients with heart failure hospitalized in the United States and Canada. , 2005, Archives of internal medicine.
[7] C. O'connor,et al. Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. , 2008, Archives of internal medicine.
[8] K. Furie,et al. Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2008, Circulation.
[9] C. O'connor,et al. Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. , 2007, American heart journal.
[10] Harlan M Krumholz,et al. ACC/AHA Clinical Performance Measures for Adults with Chronic Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society , 2005, Circulation.
[11] R. Berger,et al. Influence of age and in‐patient care on prescription rate and long‐term outcome in chronic heart failure: a data‐based substudy of the EuroHeart Failure Survey , 2005, European journal of heart failure.
[12] J. Cleland,et al. NHS heart failure survey: a survey of acute heart failure admissions in England, Wales and Northern Ireland , 2007, Heart.
[13] R. Allman,et al. Age-Related Underutilization of Angiotensin-Converting Enzyme Inhibitors in Older Hospitalized Heart Failure Patients , 2002, Southern medical journal.
[14] G. Fonarow,et al. Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). , 2006, Journal of cardiac failure.
[15] D. Kazi,et al. Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure. , 2008, Cardiology clinics.
[16] Björn Agvall, Ulf Dahlström. Patients in primary health care diagnosed and treated as heart failure, with special reference to gender differences , 2001, Scandinavian journal of primary health care.
[17] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[18] C. Yancy,et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. , 2007, JAMA.
[19] A. Laupacis,et al. Risk-treatment mismatch in the pharmacotherapy of heart failure. , 2005, JAMA.
[20] J. Daubert,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.
[21] B. Knight,et al. Disparities in the use of primary prevention and defibrillator therapy among blacks and women. , 2006, The American journal of medicine.
[22] S. Normand,et al. American College of Cardiology and American Heart Association Methodology for the Selection and Creation of Performance Measures for Quantifying the Quality of Cardiovascular Care , 2005 .